Real-time Stock quotes, portfolio, LIVE TV and more.
|
Aug 02, 2012, 07.51 PM IST
Glenmark Pharma has disappointed the street by its first quarter numbers as consolidated net profit fell by 62.5% year-on-year to Rs 78.3 crore in the quarter, which was far lower than forecast of Rs 131 crore.
Consolidated net sales increased 19.8% to Rs 1,040 crore from Rs 868 crore year-on-year, which was almost in-line with analysts' expectations of Rs 1,028 crore. The share rose just 0.36% to close at Rs 387.60 amid huge volumes.
Related News Set email alert for Tags: Glenmark Pharma
|
Action in Glenmark Pharma
News Videos
|